The fact that we found an association between sTfR levels and the occurrence of organ changes in SLE patients, without a correlation of this parameter with disease activity as measured by SLEDAI, may allow us to consider sTfR determination as a potential prognostic marker for the occurrence of selected organ changes in SLE patients. The gene discussed is TFRC; the disease is systemic lupus erythematosus.